Background As cancer therapies increase in their complexity, effective communication
among patients, physicians, and research staff is critical for optimal clinical trial …

Early integration of palliative care (PC) is recommended as standard of care for patients with
advanced cancer. However, challenges remain for both medical oncologists and PC …

Background Palliative care provision should be driven by high quality research evidence.
However, there are barriers to conducting research. Most research attention focuses on …

Many factors influence patients' decisions to participate in clinical trials. For many, the
primary motivation is the possibility that they might derive some benefit from participation …

Background Participants considering early-phase cancer clinical trials (CTs) need to
understand the unique risks and benefits prior to providing informed consent. This …

Metastatic uveal melanoma (mUM) is a rare cancer with poor prognosis, but novel
treatments are emerging. Currently, there are no mUM-specific health-related quality of life …

Background Recruitment of cancer clinical trial (CCT) participants, especially participants
representing the diversity of the US population, is necessary to create successful …

To understand how patients perceive their experiences leading up to, during, and after a
clinical trial, and the relationship these experiences had with future willingness to …

This research is centred in the specialty of early phase cancer research–the branch of
clinical research that focuses on phase one and phase two clinical trials. The aim was to …

Clinical nurses need learning programs that are useful in nursing support for patients'
decision-making (NSPDM) regarding cancer clinical trials (CCTs). The usefulness of the …